Evidence map›Paper›PMID 34786457›Full record

ArticleCanadian oncology nursing journal = Revue canadienne de nursing oncologique2021

The post-treatment return-to-work transition experience for breast cancer survivors under 50 years of age.

Asma Fadhlaoui, Hazar Mrad, Billy Vinette, Karine Bilodeau

Abstract read
In one paragraph

Article in Canadian oncology nursing journal = Revue canadienne de nursing oncologique, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Gender differences in employment disruption and return to work among cancer survivors in South Korea.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  4. Recovering or working: women's experiences of working while coping with cancer: a qualitative study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Asma FadhlaouiFaculty of Nursing, Université de Montréal (Quebec), Centre de recherche de l'Hôpital Maisonneuve-Rosemont.
Hazar MradFaculty of Nursing, Université de Montréal (Quebec).
Billy VinetteFaculty of Nursing, Université de Montréal (Quebec), Centre for Innovation in Nursing Education (CIFI).
Karine BilodeauFaculty of Nursing, Université de Montréal (Quebec), Centre for Innovation in Nursing Education (CIFI), Centre de recherche de l'Hôpital Maisonneuve-Rosemont.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study is to explore the experience of cancer survivors less than 50 years of age, as they transition back to work after the end of treatment. Eight survivors took part in this exploratory qualitative study. The results of the iterative content analysis suggest that these survivors want to put their illness-focused life behind them and resume a "normal" existence, of which a return to work is an integral part. The return-to-work transition is also influenced by various personal, family and societal factors that can facilitate or inhibit the experience. Lastly, a number of distinct challenges and a higher level of vulnerability must be taken into consideration by healthcare professionals to be able to better support these survivors transitioning back to work.

Indexed as

breast cancercancer survivorshipqualitative studyreturn to worktransitionunder 50 years of agewoman

Identifiers

PMID34786457
PMCPMC8565444

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.